17th Annual Pain Therapeutics (description)


Address:Copthorne Tara Hotel, Scarsdale Place, Kensington, London, , United Kingdom W8 5SY
Phone:+44 (0)207827 6162
Event dates:5/22/2017 - 5/23/2017 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 17th Annual Pain Therapeutics


Topics to be Covered:

  • Science, Health and Medicine
Organizer phone:+44 (0)207827 6162
Offering type:Conference
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:SMi Group
Est. # of exhibitors:
Currency:British Pounds
CE Credits:
Organizer URL


Created with an expert scientific advisory board, Pain Therapeutics 2017 will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.

Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.

Exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.


. Anthony Jones, Prof of Neuro-Rheumatology, University of Manchester
. Dr Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology, Zoetis
. Dr Joseph W. Stauffer, CMO, Cara Therapeutics
. Dr Stephen Doberstein, Senior VP and CSO, Nektar Pharmaceuticals
. Dr Iain Chessell, Head of Neuroscience, AstraZeneca
. Dr Randall Stevens, CMO, Centrexion Therapeutics
. Dr Richard Butt, CEO, Apollo Therapeutics
. Prof Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutica
. Dr Narender Gavva, Scientific Director, Amgen
. Dr Thomas Christoph, Head of Pharmacology and Biomarker Development, Grunenthal
. Dr Ian Bell, Principal Scientist, MSD, USA

The agenda also features talks from Lilly UK, Novartis, Mundipharma + more!


. New guideline on the clinical development of pain medicine
. Strategies to minimise risk of opioid dependence
. Evaluate the translation gap with case studies from a pre-clinical and clinical perspective
. Examine the use of animal models to study pain pathways
. Big Pharma updates on Neuropathic pain

Earlybird savings online


Time: 8:30 am to 5:00 pm

Registration Fee Details:

Conference + 1 Workshop: GBP 2098
Conference: GBP 1499

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Teri Arri
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Organizer Phone+44 (0)207827 6162
Structural makeupOrganization
Host Sponsor; Other SponsorsSMi Group
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesInternational
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA

Sign In/Sign Out
About Us
Contact Us